You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Investigational Drug Information for Bicifadine


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Bicifadine?

Bicifadine is an investigational drug.

There have been 5 clinical trials for Bicifadine. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2004.

The most common disease conditions in clinical trials are Back Pain, Low Back Pain, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are DOV Pharmaceutical, Inc., XTL Biopharmaceuticals, and [disabled in preview].

Recent Clinical Trials for Bicifadine
TitleSponsorPhase
A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral NeuropathyXTL BiopharmaceuticalsPhase 2
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With DiabetesXTL BiopharmaceuticalsPhase 2
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back PainDOV Pharmaceutical, Inc.Phase 3

See all Bicifadine clinical trials

Clinical Trial Summary for Bicifadine

Top disease conditions for Bicifadine
Top clinical trial sponsors for Bicifadine

See all Bicifadine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.